AusBiotech Ltd. & Beacon to Partner on Key Investment Events
Published: Sep 26, 2012
The Hong Kong-based Beacon Events, serves the increasingly important emerging markets of Asia, providing cutting-edge, market-driven programs and synergy with AusBiotech’s move into the fast-growing investment hub in Hong Kong. Hong Kong, with its direct access to China, is developing as a pivotal hub in the Asia Pacific region, and this is especially important from an Australian perspective as a regional neighbour. Private investment by Chinese and Hong Kong-based venture capitalists has burst forth in recent years, peaking at $1billion in 2010 and reaching $573 million in 2011. The average Chinese VC investment in life sciences in 2011 was $ 25 million, compared to $10 million in the US. Mr Glenn Cross, Chief Operating Officer at AusBiotech said: “While there are already numerous examples of Sino-Australian partnership in life sciences, evidenced in part by the 50 Hong Kong fund managers currently investing in Australian public biotech companies, we expect this interest to grow vastly in the coming years.”
“Our partnership with Beacon Event looks to its expertise in Hong Kong and providing finance and investment events for the resources sector, which is naturally converging with biotechnology as it shares the same investor profile.”
Daniel Kirwin, Chief Executive of Beacon said: “We are delighted to be working with AusBiotech in Australia and Asia. Our combined efforts and expertise will produce world class large scale events for the biotechnology sector.”
“The inaugural Hong Kong invest event in June 2013 will be well placed to deliver investment, education and networking opportunities. We expect it to be the must-attend event in Asia region.”
The first event, AsiaBiotech Invest, will bring together the most influential decision makers, from within international biotech companies, the investment community, governments and professional services.
3 – 5 June 2013 at Sheraton Hong Kong Hotel & Towers, Kowloon, Hong Kong
For further media information and interviews, please contact: Lorraine Chiroiu, AusBiotech, Communication Manager, +61 (0) 429 801 118 or email@example.com
For further information in regard to Beacon Events, please contact: Daniel Kirwin, Chief Executive at firstname.lastname@example.org
For further information in regard to AusBiotech Investment, please contact: Hayley Laing, AusBiotech, Investment Program Manager at email@example.com
About AusBiotech and AusBiotech Investment
AusBiotech is Australia's biotechnology industry organisation working on behalf of over 3,000 members in the areas of human health, medical devices, food technology, agriculture, environmental and industrial biotechnology, for more than 25 years. AusBiotech is dedicated to the development, growth and prosperity of the Australian biotechnology industry.
AusBiotech Investment offers a comprehensive series of national and international investor events as a global platform for Australian life sciences companies to showcase their company’s offering for partnership and investment.
About Beacon Events
Beacon is a major conference and exhibition organiser producing first class international events that meet the challenges facing major business sectors today – including specialising in finance and investment events. Beacon’s focus is on large-scale, must-attend events that are independently researched and tailored to deliver unbiased and focused market information.